Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung caner

Molecular Pharmaceutics

Volumn 9, Issue 8, 2012, Pages 2280-2289

  Yang, Yang ^a   Hu, Yunxia ^a   Wang, Yuhua ^a   Li, Jun ^a,b   Liu, Feng ^a   Huang, Leaf ^a  

^a UNC Hamner Institute for Drug Safety Sciences   (United States)

^b Biomedical Group   (United States)

Author keywords

angiogenesis; apoptosis; drug delivery; nanoparticle; NSCLC; siRNA

Indexed keywords

NANOPARTICLE; PROTEIN MDM2; SIGMA OPIATE RECEPTOR; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; GENES, MYC; HUMANS; MICE; MICE, NUDE; NANOPARTICLES; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864687264     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300152v     Document Type: Article

References (33)

1. Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA-Cancer J. Clin. 2011, 61 (4) 212-236
2. Alberg, A. J.; Ford, J. G.; Samet, J. M. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 2007, 132 (3 Suppl.) 29S-55S (Pubitemid 47502798)
3. Molina, J. R.; Adjei, A. A.; Jett, J. R. Advances in chemotherapy of non-small cell lung cancer Chest 2006, 130 (4) 1211-1219 (Pubitemid 44583755)
4. Huang, L.; Liu, Y. In vivo delivery of RNAi with lipid-based nanoparticles Annu. Rev. Biomed. Eng. 2011, 13, 507-530
5. Schiffelers, R. M.; Ansari, A.; Xu, J.; Zhou, Q.; Tang, Q.; Storm, G.; Molema, G.; Lu, P. Y.; Scaria, P. V.; Woodle, M. C. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle Nucleic Acids Res. 2004, 32 (19) e149
6. Li, J.; Yang, Y.; Huang, L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor J. Controlled Release 2012, 158 (1) 108-114
7. LeGeros, R. Z. Calcium Phosphate-Based Osteoinductive Materials Chem. Rev. 2008, 108 (11) 4742-4753
8. Epple, M.; Ganesan, K.; Heumann, R.; Klesing, J.; Kovtun, A.; Neumann, S.; Sokolova, V. Application of calcium phosphate nanoparticles in biomedicine J. Mater. Chem. 2010, 20, 18-23
9. Cheang, T.-y.; Wang, S.-m.; Hu, Z.-j.; Xing, Z.-H.; Chang, G.-q.; Yao, C.; Liu, Y.; Zhang, H.; Xu, A.-W. Calcium carbonate/CaIP6 nanocomposite particles as gene delivery vehicles for human vascular smooth muscle cells J. Mater. Chem. 2010, 20 (37) 8050-8055
10. Li, J.; Chen, Y.-C.; Tseng, Y.-C.; Mozumdar, S.; Huang, L. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery J. Controlled Release 2010, 142 (3) 416-421
11. Alvarez, M.; Roman, E.; Santos, E. S.; Raez, L. E. New targets for non-small-cell lung cancer therapy Expert Rev. Anticancer Ther. 2007, 7 (10) 1423-1437 (Pubitemid 351826908)
12. Momand, J.; Zambetti, G. P.; Olson, D. C.; George, D.; Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 1992, 69 (7) 1237-1245
13. Vassilev, L. T. MDM2 inhibitors for cancer therapy Trends Mol. Med. 2007, 13 (1) 23-31 (Pubitemid 46027725)
14. Ponzielli, R.; Katz, S.; Barsyte-Lovejoy, D.; Penn, L. Z. Cancer therapeutics: Targeting the dark side of Myc Eur. J. Cancer 2005, 41 (16) 2485-2501 (Pubitemid 41540625)
15. Adhikary, S.; Eilers, M. Transcriptional regulation and transformation by Myc proteins Nat. Rev. Mol. Cell Biol. 2005, 6 (8) 635-645 (Pubitemid 41081267)
16. Kaya, A.; Čiledag, A.; Gulbay, B. E.; Poyraz, B. M.; Čelik, G.; Sen, E.; Savas, H.; Savas, I. The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients Respir. Med. 2004, 98 (7) 632-636 (Pubitemid 38949927)
17. Shimanuki, Y.; Takahashi, K.; Cui, R.; Hori, S.; Takahashi, F.; Miyamoto, H.; Fukurchi, Y. Role of Serum Vascular Endothelial Growth Factor in the Prediction of Angiogenesis and Prognosis for Non-small Cell Lung Cancer Lung 2005, 183 (1) 29-42 (Pubitemid 41264745)
18. Banerjee, R.; Tyagi, P.; Li, S.; Huang, L. Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells Int. J. Cancer 2004, 112 (4) 693-700 (Pubitemid 39425952)
19. Inuzuka, H.; Tseng, A.; Gao, D.; Zhai, B.; Zhang, Q.; Shaik, S.; Wan, L.; Ang, X. L.; Mock, C.; Yin, H.; Stommel, J. M.; Gygi, S.; Lahav, G.; Asara, J.; Xiao, Z.-X. J.; Kaelin, W. G., Jr.; Harper, J. W.; Wei, W. Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCF[beta]-TRCP Ubiquitin Ligase Cancer Cell 2010, 18 (2) 147-159
20. Dai, M.-S.; Arnold, H.; Sun, X.-X.; Sears, R.; Lu, H. Inhibition of c-Myc activity by ribosomal protein L11 EMBO J. 2007, 26 (14) 3332-3345 (Pubitemid 47123541)
21. Reich, S. J.; Fosnot, J.; Kuroki, A.; Tang, W.; Yang, X.; Maguire, A. M.; Bennett, J.; Tolentino, M. J. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model Mol. Vision 2003, 9, 210-6 (Pubitemid 38097589)
22. Yang, Y.; Bai, Y.; Xie, G.; Zhang, N.; Ma, Y. P.; Chen, L. J.; Jiang, Y.; Zhao, X.; Wei, Y. Q.; Deng, H. X. Efficient inhibition of non-small-cell lung cancer xenograft by systemic delivery of plasmid-encoding short-hairpin RNA targeting VEGF Cancer Biother. Radiopharm. 2010, 25 (1) 65-73
23. Schiller, J. H.; Harrington, D.; Belani, C. P.; Langer, C.; Sandler, A.; Krook, J.; Zhu, J.; Johnson, D. H. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N. Engl. J. Med. 2002, 346 (2) 92-98 (Pubitemid 34438899)
24. Raben, D.; Helfrich, B.; Bunn, P. A. Targeted therapies for non-mall-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective Int. J. Radiat. Oncol. Biol. Phys. 2004, 59 (2) S27-S38
25. Ellis, L. M.; Hicklin, D. J. VEGF-targeted therapy: mechanisms of anti-tumour activity Nat. Rev. Cancer 2008, 8 (8) 579-591
26. Yang, Y.; Li, J.; Liu, F.; Huang, L. Systemic Delivery of siRNA via LCP Nanoparticle Efficiently Inhibits Lung Metastasis Mol. Ther. 2012, 20 (3) 609-615
27. Zhang, M.; Ishii, A.; Nishiyama, N.; Matsumoto, S.; Ishii, T.; Yamasaki, Y.; Kataoka, K. PEGylated Calcium Phosphate Nanocomposites as Smart Environment-Sensitive Carriers for siRNA Delivery Adv. Mater. 2009, 21 (34) 3520-3525
28. Epple, M.; Ganesan, K.; Heumann, R.; Klesing, J.; Kovtun, A.; Neumann, S.; Sokolova, V. Application of calcium phosphate nanoparticles in biomedicine J. Mater. Chem. 2010, 20 (1) 18-23
29. Zhang, M.; Kataoka, K. Nano-structured composites based on calcium phosphate for cellular delivery of therapeutic and diagnostic agents Nano Today 2009, 4 (6) 508-517
30. Kakizawa, Y.; Furukawa, S.; Kataoka, K. Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery J. Controlled Release 2004, 97 (2) 345-356 (Pubitemid 38759491)
31. Kakizawa, Y.; Furukawa, S.; Ishii, A.; Kataoka, K. Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer J. Controlled Release 2006, 111 (3) 368-370
32. Li, S. D.; Huang, L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting J. Controlled Release 2010, 145 (3) 178-181
33. Tabakovic, A.; Kester, M.; Adair, J. H. Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applications Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2012, 4 (1) 96-112